Sign up for the QMED & MD+DI Daily newsletter.
Another Bombshell for Guidant ICDs
An FDA analysis conducted last year concluded that Guidant implantable cardioverter-defibrillators were 10 times more likely to fail than the company had let on, Bloomberg News reports, citing documents unsealed as part of a product-liability lawsuit against Guidant (now part of Boston Scientific) in Texas. When Guidant began its recall, it said that no more than 292 of the devices would fail. But the FDA analysis placed that figure at around 3200.
Pedersen's POV graphic featuring the headshot of MD+DI Senior Editor Amanda Pedersen and a pull quote from the latest edition of her opinion column.
BioSig's Ridiculously Sparse Layoff Announcement Reeks of CallousnessFeb 26, 2024|3 Min Read
Sourcing Electrical Components: Are We Back to Normal?Feb 26, 2024|6 Min Read
Your Smartwatch Can’t Measure Blood Glucose Levels… YetFeb 26, 2024|3 Min Read
Medtech in a Minute: Medtronic Pulls the Plug on Ventilators and MoreFeb 26, 2024|1 Min Read